title: Expression of the T-cell transcription factors, GATA-3 and T-bet, in the neoplastic cells of Hodgkin lymphomas.
abstract: Since Hodgkin and Reed-Sternberg (HRS) cells of Hodgkin lymphoma (HL) generally have immunoglobulin gene rearrangements, they are considered to be of B-cell origin. One of the characteristics of HRS cells is a prominent production of various cytokines and chemokines. Cytokine production is generally driven by expression of T-cell transcription factors (TFs). Only limited information is available on the expression of T-cell TFs in HL. Expression of four T-cell TFs and the target cytokine spectrum of these TFs were analyzed in six HL and three large B-cell lymphoma (LBCL) cell lines using quantitative PCR. ERM expression was observed in all HL and LBCL cell lines. Out of HL cell lines, T-bet was expressed in five, GATA-3 in four, and c-Maf in two cell lines. Immunohistochemistry in HL tissues revealed that in 11 of 12 (92%) of the classical HL cases HRS cells were GATA-3 and/or T-bet positive. In three of six cases of nodular lymphocyte predominance type of HL, the neoplastic cells were T-bet positive. Overall, the T-cell TF and cytokine profiles of the HL cell lines showed a considerable degree of consistency. The expression of T-cell TFs may explain the production of various cytokines by HL cell lines and HRS cells.
authors.affiliation: Department of Pathology and Laboratory Medicine, Groningen University Medical Center, Hanzeplein 1, P.O. Box 30.001 9700 RB Groningen, The Netherlands.
authors.forename: Cigdem
authors.initials: C
authors.lastname: Atayar
authors.forename: Sibrand
authors.initials: S
authors.lastname: Poppema
authors.forename: Tjasso
authors.initials: T
authors.lastname: Blokzijl
authors.forename: Geert
authors.initials: G
authors.lastname: Harms
authors.forename: Marcel
authors.initials: M
authors.lastname: Boot
authors.forename: Anke
authors.initials: A
authors.lastname: van den Berg
mesh_terms: D001402:B-Lymphocytes / Q000473:pathology; D001483:Base Sequence; D045744:Cell Line, Tumor; D017931:DNA Primers; D004268:DNA-Binding Proteins / Q000235:genetics*; D050990:GATA3 Transcription Factor; D015322:Gene Rearrangement, B-Lymphocyte / Q000235:genetics; D006689:Hodgkin Disease / Q000235:genetics* / Q000473:pathology; D006801:Humans; D007150:Immunohistochemistry; D007378:Interleukins / Q000235:genetics; D016133:Polymerase Chain Reaction; D016539:Reed-Sternberg Cells / Q000473:pathology; D020825:T-Box Domain Proteins; D013601:T-Lymphocytes / Q000473:pathology; D015534:Trans-Activators / Q000235:genetics*; D014157:Transcription Factors / Q000235:genetics*; D000098815:T-bet Transcription Factor
chemical_list: D017931:DNA Primers; D004268:DNA-Binding Proteins; D050990:GATA3 Transcription Factor; C494749:GATA3 protein, human; D007378:Interleukins; D020825:T-Box Domain Proteins; D000098815:T-bet Transcription Factor; D015534:Trans-Activators; D014157:Transcription Factors